BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 75 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,795,414 | +36.9% | 775,957 | +12.5% | 0.00% | 0.0% |
Q1 2024 | $3,503,717 | -22.2% | 689,708 | -8.3% | 0.00% | 0.0% |
Q4 2023 | $4,504,390 | -17.1% | 751,985 | -2.0% | 0.00% | 0.0% |
Q3 2023 | $5,434,403 | +1.6% | 767,571 | +1.1% | 0.00% | 0.0% |
Q2 2023 | $5,346,768 | -4.4% | 759,484 | +13.3% | 0.00% | 0.0% |
Q1 2023 | $5,592,871 | -28.0% | 670,608 | -0.9% | 0.00% | -50.0% |
Q4 2022 | $7,772,213 | -8.1% | 677,022 | +0.8% | 0.00% | 0.0% |
Q3 2022 | $8,460,000 | +29.0% | 671,412 | +8.3% | 0.00% | +100.0% |
Q2 2022 | $6,559,000 | -54.8% | 619,871 | -30.5% | 0.00% | -66.7% |
Q1 2022 | $14,506,000 | +22.1% | 892,108 | +4.0% | 0.00% | +50.0% |
Q4 2021 | $11,882,000 | +10.6% | 857,932 | +14.7% | 0.00% | 0.0% |
Q3 2021 | $10,747,000 | -7.9% | 747,821 | +1.3% | 0.00% | 0.0% |
Q2 2021 | $11,672,000 | +60.6% | 738,313 | +3.3% | 0.00% | +100.0% |
Q1 2021 | $7,270,000 | +28.7% | 714,901 | -5.7% | 0.00% | 0.0% |
Q4 2020 | $5,647,000 | +126.2% | 758,102 | +4.4% | 0.00% | 0.0% |
Q3 2020 | $2,496,000 | -37.0% | 726,434 | -12.6% | 0.00% | 0.0% |
Q2 2020 | $3,959,000 | +204.3% | 830,918 | +27.7% | 0.00% | – |
Q1 2020 | $1,301,000 | -30.7% | 650,638 | +19.6% | 0.00% | – |
Q4 2019 | $1,876,000 | +50.6% | 543,801 | +25.1% | 0.00% | – |
Q3 2019 | $1,246,000 | -27.3% | 434,680 | -3.9% | 0.00% | – |
Q2 2019 | $1,714,000 | -76.7% | 452,282 | -49.9% | 0.00% | -100.0% |
Q1 2019 | $7,348,000 | +67.6% | 902,660 | +66.2% | 0.00% | +100.0% |
Q4 2018 | $4,383,000 | +36.5% | 543,026 | +29.0% | 0.00% | 0.0% |
Q3 2018 | $3,211,000 | +37.2% | 420,825 | +3.1% | 0.00% | 0.0% |
Q2 2018 | $2,340,000 | +6.1% | 408,281 | -11.7% | 0.00% | 0.0% |
Q1 2018 | $2,205,000 | -3.2% | 462,370 | -0.4% | 0.00% | 0.0% |
Q4 2017 | $2,279,000 | +17.5% | 464,191 | +25.4% | 0.00% | 0.0% |
Q3 2017 | $1,939,000 | -5.6% | 370,031 | +0.1% | 0.00% | 0.0% |
Q2 2017 | $2,055,000 | -32.3% | 369,561 | +2.3% | 0.00% | 0.0% |
Q1 2017 | $3,035,000 | +41.8% | 361,289 | +6.8% | 0.00% | 0.0% |
Q4 2016 | $2,141,000 | +52.3% | 338,217 | +6.1% | 0.00% | – |
Q3 2016 | $1,406,000 | +61.6% | 318,879 | +4.0% | 0.00% | – |
Q2 2016 | $870,000 | +0.1% | 306,563 | -0.2% | 0.00% | – |
Q1 2016 | $869,000 | -74.1% | 307,115 | -5.5% | 0.00% | -100.0% |
Q4 2015 | $3,355,000 | -11.0% | 325,140 | -1.6% | 0.00% | 0.0% |
Q3 2015 | $3,768,000 | -35.6% | 330,543 | -15.7% | 0.00% | -50.0% |
Q2 2015 | $5,851,000 | +77.1% | 391,890 | +7.1% | 0.00% | +100.0% |
Q1 2015 | $3,304,000 | -25.8% | 365,964 | -0.1% | 0.00% | 0.0% |
Q4 2014 | $4,454,000 | +27.5% | 366,332 | +2.6% | 0.00% | 0.0% |
Q3 2014 | $3,494,000 | -57.8% | 357,210 | -45.0% | 0.00% | 0.0% |
Q2 2014 | $8,280,000 | +758.9% | 649,430 | +612.6% | 0.00% | – |
Q1 2014 | $964,000 | +11.8% | 91,135 | -19.6% | 0.00% | – |
Q4 2013 | $862,000 | -50.9% | 113,371 | -53.0% | 0.00% | – |
Q3 2013 | $1,756,000 | +1240.5% | 241,432 | +186.8% | 0.00% | – |
Q2 2013 | $131,000 | – | 84,193 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |